BioCentury
ARTICLE | Clinical News

Bristol-Myers reports first SVR data for PEG-IFN lambda

April 20, 2012 1:02 AM UTC

Bristol-Myers Squibb Co. (NYSE:BMY) reported sustained virologic response data for 118 treatment-naive patients with chronic HCV genotype 2 or 3 infection treated with PEG-Interferon lambda in the Pha...